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Abstract The possibility that some of the brain proteoglycans are receptor-like protein tyrosine phosphatases (PTPases) was investigated. Mem- 
brane-bound proteoglycan fractions were prepared from the postnuclear membrane fraction of &day-old rat brain by DEAE ion-exchange chrom- 
atography and CsCl density gradient centrifugation. The isolated proteoglycan fractions showed high PTPase specific activities together with the 
typical PTPase characteristics. Renaturation experiments indicated that chondroitin sulfate proteoglycans with 380-and 170-kDa core proteins carried 
the PTPase activity. The proteoglycan with 380-kDa core protein was identified as RPTP/S/[ bearing HNK-1 carbohydrate. 
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1. Introduction 
Diverse cellular processes are regulated by protein tyrosine 
phosphorylation, the level of which is determined by the bal- 
ance of protein tyrosine kinase and protein tyrosine phosphat- 
ase (FTPase) activities [1,2]. Recently, many types of receptor- 
like PTPases have been cloned and characterized [l-3]. 
Although ligands of the receptor-like PTPases are unknown, 
recent studies have suggested that some types of receptor-like 
PTPases are directly involved in cell-cell adhesion, and that the 
activities of PTPases are regulated by cell-substrate adhesion 
P-4. 
On the other hand, proteoglycans are now thought to play 
important roles in the regulation of cell adhesion, growth, mo- 
tility and differentiation [7]. Proteoglycans are a family of pro- 
teins bearing sulfated glycosaminoglycans, which bind many 
extracellular matrix components and growth factors through 
their core protein and glycosaminoglycan portions [7]. 
Previously, we identified a phosphate-buffered saline-soluble 
chondroitin sulfate proteoglycan with a 300-kDa core protein 
(6B4 proteoglycan) using a monoclonal antibody (MAb6B4) 
[8]. We cloned cDNAs encoding this proteoglycan from a &tl 1 
rat whole brain cDNA library. Sequence analysis of the isolated 
cDNA clones indicated that 6B4 proteoglycan is highly homol- 
ogous to a human receptor-like PTPase, RPTPjVc [3,9]. Simul- 
taneously, Maurel et al. [lo] reported a cDNA encoding a 
chondroitin sulfate proteoglycan, phosphacan, from rat brain, 
and it became clear that 6B4 proteoglycan is identical to phos- 
phacan. Phosphacan is considered from its cDNA structure to 
be an alternatively spliced extracellular variant of RPTPj?/[. 
Therefore, we attempted to identify proteoglycan-type PTPases 
in the rat brain, where many types of proteoglycans and 
PTPases are known to be present [l 1,121. Here, we provide the 
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first evidence that early postnatal rat brain indeed contains 
multiple proteoglycan-type PTPases, one of which is RPTPjU[. 
2. Materials and methods 
2.1. Partial purification of proteoglycan-type PTPases 
Thirty grams of whole brain tissue from I-day-old Sprague-Dawley 
rats was homogenized in 8 volumes of 5 mM EDTA, 1 mM dithiothre- 
itol (DTT), 0.1 mM phenylmethylsulphonyl fluoride (PMSF), 10 PM 
leupeptin, 10 PM pepstatin A, 1 mM benzamidine and 50 mM Tris- 
HCI, pH 7.4 (buffer A) containing 0.32 M sucrose with a glass-Teflon 
Potter homogenizer. The homogenate was centrifuged at 1,000 x g for 
5 min at 2°C and the resultant precipitate was washed under the same 
conditions. Combined supematants were centrifuged at 105,000 x g for 
60 min at 2°C to precipitate the postnuclear fraction. After washing 
once with 100 ml of 0.1 M sucrose/O.2 M NaCVbuffer A, the membrane 
proteins were solubilized in 200 ml of 1% CHAPS/O.1 M NaCYbuffer 
A, and insoluble material was removed by centrifugation at 20,000 x g 
for 60 min at 2°C. The supcmatant was applied to a DEAE-Toyopearl 
column (2.5 x 5 cm; Tosoh Corporation) equilibrated with 0.5% 
CHAPS, 1 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 1OpM leupeptin, 
10 PM pepstatin A, 1 mM benzamidine, 50 mM Tris-HCI, pH 7.4 
(buffer B) containing 0.1 M NaCI. The column was washed with 0.25 
M NaCUbuffer B, and then the proteins were eluted with 0.6 M NaCY 
buffer B. After adjusting the density to 1.43 g/ml with solid CsCI, the 
eluate was centrifuged at 77,000 rpm at 4’C for 35 h using a Beckman 
TLA100.4 rotor. After centrifugation, the samples were collected in 10 
fractions. 
2.2. Preparation of substrate and assay of PTPase activity 
Tyrosine phosphorylation of Raytide (Oncogene Science) was car- 
ried out according to the method described by Guan et al. [13]. 
Dephosphorylation of [32P]phosphotyrosine-labeled Raytide (PTPase 
assay) was measured as described by Krueger et al. [3]. Hydrolysis of 
p-nitrophenyl phosphate (pNPPase assay) was carried out as described 
by Guan et al. [13]. One unit is defined as the activity which releases 
1 nmol of phosphate per min. 
2.3. Isolation of phosphacanl6B4 proteoglycan and RPTPjU(cDNA 
clones 
A Igt 11 cDNA library was constructed with poly(A)’ RNA from the 
whole brain of 18-day-old Sprague-Dawley rats as a template using 
random primers. Positive clones were isolated by screening this cDNA 
library with rabbit antiserum to the purified 6B4 proteoglycan and an 
adult Sprague-Dawley rat brain ilgtl 1 cDNA library (Clonetech, USA) 
with probes prepared from the previously isolated clones. The clones 
thus isolated were as follows (cDNAs are common or belong to RPTPF/ 
5 unless otherwise mentioned [9,10]): LrPG-9 (carrying nucleotide 
1,639-2,294), ArPG-10 (2,20&4,520), ilrPG-11 (2,097-3,774), ilrPG-22 
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(1,5266,274; 
/ZrPG-51 (-115 
dvRPTP/I/O, ArPG-31 (2,427-5,715; phosphacan), 
-1,291) ilrPG-61 (462-2,257), ilrPG-222 (1,9647,746; 
dvRPTP&) and /ZrPG-302 (1,5266,050). Nucleotide residues are 
numbered beginning with the first residue of the initiative methionine. 
2.4. Preparation of antiserum against he C-terminal portion of 
phosphacanl6B4 proteoglycan (antiserum 31-5) 
To adjust the reading frame and to create appropriate cloning sites, 
the AccI (4,183)IEcoRI (5,034) cDNA fragment from ilrPG-31 was 
once subcloned in the pBSI1 ks(+) vector and then inserted into 
pGEX4T-2 (Pharmacia) using XhoIINotI sites. The resultant construct 
(pGEX31-5) expressed the C-terminal portion of phosphacam6B4 pro- 
teoglycan ( amino acid residues 1,360-1,616) as a fusion protein with 
glutathione S-transferase (GST) in DH5a cells. The cDNA derived 
portion was prepared from the fusion protein with Pharmacia GST 
purification module and used to immunize New Zealand white rabbits. 
2.5. Other methodr 
Protein concentration was determined using a BioRad protein assay 
kit with bovine serum albumin as a standard. Enzyme activity was 
recovered from the gel using the procedure described by Hager and 
Burgess [14], in that renaturation of proteins was performed for 15 h 
after dilution of guanidium chloride. Purification of phosphate-buff- 
ered saline-soluble proteoglycan was performed as described previously 
[15]. Digestion of proteoglycans with protease-free chondroitinase ABC 
(Seikagaku Corporation) was carried out as described previously except 
that N-ethylmaleimide was omitted [8]. 
3. Results 
3.1. Partial purljication and characterization of proteoglycan- 
type PTPases 
For the purification of membrane-bound proteoglycans, the 
postnuclear fraction prepared from g-day-old rat whole brains 
was solubilized with 1% CHAPS. When the solubilized material 
was applied to a DEAE-Toyopearl column, most of the PTPase 
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Fig. 1. CsCl density gradient centrifugation of proteins eluted from a 
DEAE-Toyopearl column. CHAPS-extract of the postnuclear fraction 
from rat brain was applied to a DEAE-Toyopearl column, and proteins 
were eluted with 0.6 M NaCl after washing with 0.25 M NaCl. The 
eluted proteins were fractionated by CsCl density gradient centrifuga- 
tion. After centrifugation, the sample was fractionated into 10 tubes 
(500 @/tube), and protein concentration (o), density (---), and PTPase 
activity (0) of each fraction were measured. The fractions designated 
I, II and III were analyzed further. 
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Fig. 2. Renaturation of PTPase activity after SDS-PAGE of fractions 
I, II and III. Aliquots of fractions I(A), II(B) and III(C) were digested 
with protease-free chondroitinase ABC (+) or incubated under the same 
conditions without the enzyme (-), and then applied to 5% SDS-PAGE. 
Left panels: After electrophoresis, the gel was cut into 2-mm slices, from 
which proteins were eluted and renatured. PTPase activity was meas- 
ured using [‘2P]phosphotyrosine-labeled Raytide; chondroitinase ABC- 
treated samples (o), intact samples (0). Right panels: Aliquots of the 
chondroitinase ABC-treated (+) or untreated (-) samples were electro- 
phoresed on the same gel that used for renaturation, and the proteins 
were stained with Coomassie brilliant blue. Arrows indicate the posi- 
tions of peaks of PTPase activity. Arrowheads indicate the positions of 
molecular weight markers of 200 kDa and 116 kDa (myosin and 
/I-galactosidase, respectively). 
activity was eluted from the column by 0.25 M NaCl. However, 
-8% of the total activity remained in the column, and was eluted 
by 0.6 M NaCl. This highly negatively charged material was 
fractionated by CsCl density gradient centrifugation, which is 
often used to separate proteoglycans from normal protein. As 
shown in Fig. 1, most of the PTPase activity was recovered 
from the middle portion of the gradient @ = 1.35-1.55 g/ml), 
while nearly all of the protein remained on the top. 
To characterize this phosphatase activity, three fractions (I, 
II and III) from CsCl density gradient centrifugation were 
selected. Fig. 2 shows the results of SDS-PAGE analysis of 
these fractions. Before chondroitinase ABC digestion, the frac- 
tions yielded a very diffuse smear on electrophoresis (Mr > 
1.0 x 10’). However, discrete protein bands were observed in 
place of the smear after digestion (Fig. 2, right panels). In 
fraction I, 380-, 300-, 140- and 125-kDa bands were detected 
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as the major species, and 380-, 230-, 170-, 140-, and 125kDa 
bands in fraction II. In fraction III, many core protein bands 
appeared after chondroitinase ABC digestion. 
3.2. Properties of the PTPases in fractions I-III 
The PTPase activity in these fractions were strongly inhibited 
by well-known PTPase inhibitors, vanadate, molybdate, zinc 
ion, and poly(Glu,Tyr). On the other hand, NaF and okadaic 
acid exerted no effects (data not shown). All known PTPases 
show optimal activity in the acidic range with pNPP as a sub- 
strate, and at neutral pH with peptide substrates [ 161. This was 
also true for fractions I-III: Optimal activities of fractions I, II, 
and III were at pH 5.8,6.3 and 5.8 withpNPP, respectively; pH 
7.4 for all three fractions with [32P]Raytide. Km values of these 
fractions for pNPP were all 5 mM, and those for [32P]Raytide 
were 20 PM. All these properties of the phosphatases in frac- 
tions I-III were comparable to those of other PTPases reported 
previously [16]. Specific activities of fractions I, II and III for 
32P-Raytide were 2,060, 2,810 and 1,300 nmol/min/mg, respec- 
tively. 
3.3. Assignment of PTPase activities to specific proteoglycan 
core proteins 
From the high specific activity in each fraction, it was ex- 
pected that the protein bands carrying the PTPase activities 
must be detectable as visible bands when separated on a gel. 
Accordingly, we next performed renaturation of the PTPases 
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Fig. 3. Detection of phosphacan/6B4 proteoglycan in the soluble pro- 
teoglycan fraction with antibodies. (A) Schematic diagrams of phos- 
phacan/6B4 proteoglycan and RPTP/J/c. Both forms contain carbonic 
anhydrase-like domain (CAH) and fibronectin type III repeat (FN). In 
addition, RPTP/?/c contains a transmembrane domain (T) and two 
phosphatase domains (Dl and D2). Antiserum 31-5 was raised against 
the C-terminal region of phosphacan/6B4 proteoglycan indicated by a 
bar @GEX31-5). (B) Phosphate-buffered saline-soluble proteoglycan 
fraction prepared from 20-day-old rat whole brain was applied to 5% 
SDS-PAGE before (-) or after (+) chondroitinase ABC digestion. The 
proteins were stained with Coomassie Brilliant Blue (a), or analyzed by 
Western blotting using antiserum 31-5 (b), polyclonal antiserum 
against purified 6B4 proteoglycan (c), or MAb 6B4 (d). These antibod- 
ies reacted only with the phosphacan/6B4 proteoglycan (arrow). 
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Fig. 4. Identification of RPTP/V[ and phosphacan/6B4 proteoglycan 
in fractions I and II. (A) Purified phosphacan/6B4 proteoglycan (P), 
and aliquots of fraction I (I) and fraction II (II) were digested with 
protease-free chondroitinase ABC. The samples were applied to 5% 
SDS-PAGE, and the proteins were stained with Coomassie Brilliant 
Blue. (B) Aliquots of fractions I (I) and II (II) were applied to 5% 
SDS-PAGE before (-) or after (+) chondroitinase ABC digestion. After 
electrophoresis, the samples were analyzed by Western blotting using 
polyclonal antiserum against purified 6B4 proteoglycan (a), MAb 6B4 
(b), antiserum 31-5 (c) or HNK-1 monoclonal antibody (d). The arrow- 
heads indicate the positions of 380 kDa and 300 kDa species. 
after SDS-PAGE of fractions I-III. When intact proteins were 
electrophoresed, PTPase activity was detected in two broad 
peaks (Fig. 2, left panels); one near the top of the gel and the 
other with IV, around 200 kDa. After chondroitinase ABC 
digestion, the former peak shifted to a position corresponding 
to 380-kDa into a single core protein band (Fig. 2A, a and Fig. 
2B, b), and the latter peak at around 200 kDa shifted to 170 
kDa (Fig. 2B, c and Fig. 2C, d). It was possible to assign the 
enzymatic activities to the specific core protein bands in frac- 
tions I and II, but not in fraction III because of a few core 
protein bands around 170 kDa. 
3.4. Ident$cation of the 380-kDa coreprotein bandas RPTPjVc 
Phosphacan is considered to be an alternatively spliced ex- 
tracellular variant of RPTP/?/c (Fig. 3A). We prepared antise- 
rum 31-5 against the C-terminal portion of phosphacan/6B4 
proteoglycan. Not only the antiserum against the purified 6B4 
proteoglycan and MAb 6B4 but also antiserum 31-5 recog- 
nized the purified 6B4 proteoglycan (data not shown). Among 
the various soluble proteoglycans, the three antibodies specifi- 
cally recognized a 300-kDa core protein of 6B4 proteoglycan 
(Fig. 3B). Electorophoretic mobility of the core protein of puri- 
fied 6B4 proteoglycan was identical with that of the 300-kDa 
core protein species in fractions I and II (Fig. 4A). 
We next examined the possibility that some of the proteogly- 
can-type PTPases may react with antibodies against 6B4 
IO 
proteoglycan. Western blotting of fractions I and II indicated 
that both polyclonal and monoclonal antibodies against 6B4 
proteoglycan reacted with 380- and 300-kDa core protein spe- 
cies (Fig. 4B, a and b). Antiserum 31-5 also reacted with the 
380- and 300-kDa core proteins in fractions I and II (Fig. 4B, 
c). The 300-kDa core protein seems to be phosphacan/6B4 
proteoglycan recovered in the membrane fraction probably be- 
cause of the specific binding to receptors on the plasma mem- 
brane. No proteoglycan with a 380-kDa core protein was found 
in the soluble proteoglycan fraction. These results clearly indi- 
cate that the PTPase with 380-kDa core protein is RPTPjVc. 
The three kinds of antibodies did not react with 170-kDa core 
protein species (data not shown), suggesting that the PTPase 
with a 170-kDa core protein is not highly structurally related 
to RPTPjI/[. 
4. Discussion 
We demonstrated that there indeed exist multiple proteogly- 
can-type PTPases in the rat brain. RPTPp/[ was identified here 
as a membrane-bound proteoglycan with a 380-kDa core pro- 
tein. It has also been shown very recently that RPTP/I/c can be 
expressed in the form of proteoglycan by human 293 cells 
transfected with an expression plasmid encoding the full-length 
RPTP/3/6 [ 173. Besides RPTPjVc, several types of PTPases have 
clusters of possible sequences for glycosaminoglycan attach- 
ment sites (Ser-Gly or Gly-Ser). RPTPy is typical of these, and 
it is possible that the proteoglycan-type PTPase with a 170-kDa 
core protein is RPTPy [18]. 
Proteoglycans play crucial roles in cell adhesion, motility, 
growth and differentiation through the process of binding to 
various extracellular matrix molecules and growth factors [7]. 
On the other hand, the level of protein tyrosine phosphoryla- 
tion is regulated by cellular interactions with these molecules 
[ 1,2,6]. Our findings that some membrane-bound PTPases are 
proteoglycans would explain the functional overlap between 
the two classes of molecules. 
Modification of PTPases with glycosaminoglycans should be 
able to highly diversify the functional aspects of these molecules 
in cellLcell and cell-substratum interactions. Precise glycosyla- 
tion patterns can be determined only from proteoglycans puri- 
fied from tissue. This study, for the first time, succeeded in the 
partial purification of proteoglycan-type PTPases from the 
brain. Phosphacan/6B4 proteoglycan carries HNK-1 carbohy- 
drates in addition to chondroitin sulfate [8,19]. The finding that 
N. Maeah et al. IFEBS Letters 354 (1994) 67-70 
RPTPjVc is also substituted with HNK-1 carbohydrate (Fig. 
4B, d) suggests that post-translational modification of RPTPp/ 
6 is similar to that of phosphacanl6B4 proteoglycan. Future 
studies are required to determine the ligand molecules, target 
proteins, and the regulatory mechanisms of the proteoglycan- 
type PTPases. 
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